Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease

por Gupta, Pawan Kumar, Shivashankar, P., Rajkumar, M., Mahapatra, Subhendu S., Desai, Sanjay C., Dhar, Anita, Krishna, Vinay, Raviraja, N. S., Bhat, Samatha, Viswanathan, Pachaiyappan, Kannan, Suresh, Abraham, Jijy, Boggarapu, Hema, Manjuprasad, M. S., Udaykumar, K.
Publicado 2023

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

por Gupta, Pawan Kumar, Dutta, Santanu, Kala, Sanjay, Nekkanti, Muralikrishna, Desai, Sanjay C., Mahapatra, Subhendu S., Dhar, Anita, Raju, Radhakrishnan, M., Rajkumar, Behera, Arunanshu, P., Shivashankar, Raviraja, N.S., Viswanathan, Pachaiyappan, Chandrashekar, Mithun, Thej, Charan, K.V., Prasanth, Abraham, Jijy, Boggarapu, Hema, Udaykumar, K.
Publicado 2021